Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ovarian Cancer Metastatic × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2300 Uterine Cervical Neoplasms 1475 Endometrial Neoplasms 893 Fallopian Tube Neoplasms 659 Carcinoma, Ovarian Epithelial 612 Breast Neoplasms 594 Neoplasms 378 Carcinoma, Non-Small-Cell Lung 329 Colorectal Neoplasms 317 Pancreatic Neoplasms 263 Stomach Neoplasms 262 Uterine Cervical Dysplasia 236 Prostatic Neoplasms 224 Melanoma 215 Lung Neoplasms 213 Neoplasm Metastasis 178 Peritoneal Neoplasms 172 Head and Neck Neoplasms 168 Urinary Bladder Neoplasms 167 Sarcoma 166 Vulvar Neoplasms 164 Recurrence 164 Esophageal Neoplasms 163 Carcinoma, Renal Cell 158 Uterine Neoplasms 156 Triple Negative Breast Neoplasms 153 Squamous Cell Carcinoma of Head and Neck 148 Papillomavirus Infections 136 Colonic Neoplasms 136 Vaginal Neoplasms 111

Interventions

fludarabine 1 aldesleukin 1 Interleukin-2 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389229 2020-12-16

OVSTAR

Immetacyte Ltd

Phase 1/2 Withdrawn

Ovarian Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡